Squarepoint Ops »

Cognition Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-12-31 $14k 10k 1.35

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Squarepoint Ops

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Davenport & Co
BlackRock
Chescapmanager
Renaissance Technologies
Geode Capital Management
Jane Street
Millennium Management
Hilton Capital Management
Dauntless Investment Group
State Street Corporation
Voss Capital
Sigma Planning
American Financial Group

View all funds holding Cognition Therapeutics